Clinical Research Directory
Browse clinical research sites, groups, and studies.
The Microalga Phaeodactylum Tricornutum a Potential Fish Substitute?- Pharmacokinetic Study
Sponsor: University of Hohenheim
Summary
In a cross-over design, pestos enriched with different levels of the microalgae Phaeodactylumtricornutum (2-3-4%) will be tested. The bioavailability of long-chain omega-3 fatty acids, in particular EPA and carotenoids, will be analysed in blood plasma postprandially within two days after a single dose. Pharmacokinetic parameters will be calculated from the measured data. The aim of the study is to gain insight into the bioavailability of selected microalgae constituents and the acceptance of microalgae pesto.
Official title: Die Mikroalge Phaeodactylum Tricornutum Ein Potentieller Fischersatz?- Pharmakokinetische Studie
Key Details
Gender
All
Age Range
18 Years - 60 Years
Study Type
INTERVENTIONAL
Enrollment
12
Start Date
2024-04-01
Completion Date
2024-08-01
Last Updated
2024-06-10
Healthy Volunteers
Yes
Conditions
Interventions
Dried Microalgae biomass
The products to be tested are pestos enriched with different amounts of the microalgae Phaeodactylum tricornutum (3, 4 and 5%). After drying, the microalgae Phaeodactylum, which has already been used in two previous applications (application german ethic F-2020-001), is added to the pesto. Three different pestos will be produced and enriched with different amounts of the microalgae Phaeodactylum.
Locations (1)
Institute of Nutritional Medicine, University of Hohenheim
Stuttgart, Baden-Wurttemberg, Germany